Edaravone

Edaravone

SCHEMBL13292340

[2H]C([2H])([2H])C1=NN(c2ccccc2)C(=O)C1

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.77
▸ MAPT P10636 5/20 0.77
▸ MEN1 O00255 5/20 0.77
▸ ALDH1A1 P00352 5/20 0.77
▸ GAA P10253 4/20 0.77
▸ KDM4E B2RXH2 3/20 0.77
▸ TDP1 Q9NUW8 2/20 0.77
▸ CYP1A2 P05177 1/20 0.77
▸ CHRM2 P08172 1/20 0.77
▸ CYP3A4 P08684 1/20 0.77
▸ CHRM1 P11229 1/20 0.77
▸ TSHR P16473 1/20 0.77
▸ PTGS1 P23219 1/20 0.77
▸ DRD3 P35462 1/20 0.77
▸ SMN1; SMN2 Q16637 1/20 0.77
▸ APP P05067 8/20 0.64
▸ SHMT2 P34897 1/20 0.57
▸ LOX P28300 1/20 0.57
▸ POLB P06746 1/20 0.54
▸ LMNA P02545 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Edaravone SCHEMBL27972444 0.87 KMT2A (1.00) KMT2AMAPTMEN1ALDH1A1GAA
Edaravone SCHEMBL4704 0.87 KMT2A (1.00) KMT2AMAPTMEN1ALDH1A1GAA
Edaravone SCHEMBL28220108 0.86 KMT2A (0.96) KMT2AMAPTMEN1ALDH1A1GAA
Edaravone SCHEMBL27849395 0.86 KMT2A (0.96) KMT2AMAPTMEN1ALDH1A1GAA
Edaravone SCHEMBL27946869 0.86 KMT2A (0.96) KMT2AMAPTMEN1ALDH1A1GAA
Edaravone SCHEMBL29109888 0.83 KMT2A (0.90) KMT2AMAPTMEN1ALDH1A1GAA
Edaravone SCHEMBL12477822 0.80 KMT2A (0.84) KMT2AMAPTMEN1ALDH1A1GAA
Edaravone SCHEMBL8083298 0.76 MAPT (0.77) KMT2AMAPTMEN1ALDH1A1GAA
SCHEMBL12756285 0.75 MAPT (0.81) KMT2AMAPTMEN1ALDH1A1GAA
SCHEMBL28979899 0.75 KMT2A (0.71) KMT2AMAPTMEN1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100150899-A1 PYRAZOLINONE SCAVENGERS OF FREE RADICAL AUSPEX PHARMACEUTICALS, INC. (US) 2010-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100150899-A1 PYRAZOLINONE SCAVENGERS OF FREE RADICAL GPX4, PRDX5, PRDX3 KMT2A 4709/4885MAPT 3808/4885MEN1 4503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback